Summit Therapeutics to present at Barclays Healthcare Conference on March 12

Summit Therapeutics Inc.

Will present on Tuesday March 12, 2024 at 2:35pm ET.
Presentation will cover development of investigational bispecific antibody ivonescimab.
Presenters include CEO Maky Zanganeh, Chairman Robert Duggan, and other executives.
Live webcast available at www.smmttx.com; archive will be posted.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.